Sunrest Lifescience
add_icon

Sunrest Lifescience

42.90
+1.55
(3.75%)
Market Cap
18.41 Cr
PE Ratio
8.82
Volume
1,600.00
Day High - Low
42.90 - 42.90
52W High-Low
61.00 - 29.55
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
18.41 Cr
EPS
4.66
PE Ratio
8.82
PB Ratio
1.09
Book Value
38.01
EBITDA
3.00
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
12.36
Debt to Equity
0.41
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,801.60
#1 4,32,264.19
39.98
#1 54,729.00
9.71
#1 10,980
16.07
62.14
6,071.00
1,61,165.97
67.21
9,712.00
18.67
2,191
-1.02
38.37
4,390.00
1,48,577.55
66.21
11,539.40
6.99
1,911
26.24
61.73
1,292.30
1,07,859.28
19.93
33,741.20
16.73
5,725
-15.28
51.79
1,314.70
1,06,197.76
23.61
28,409.50
7.12
5,291
-57.18
40.42
2,314.90
1,05,744.36
23.07
22,909.50
13.74
3,306
#1 37.44
57.99
905.90
91,154.74
#1 18.35
23,511.00
18.55
4,615
-0.32
48.43
2,138.90
88,294.88
50.56
12,744.20
#1 20.90
2,007
7.65
47.71
1,296.50
75,300.93
21.89
32,345.60
9.43
3,484
7.59
66.14
5,355.50
64,033.04
26.89
13,458.30
3.70
2,216
1.90
40.57

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
12.20 %
Net Income Growth
900.00 %
Cash Flow Change
109.66 %
ROE
677.36 %
ROCE
206.96 %
EBITDA Margin (Avg.)
194.16 %

Yearly Financial Results

Annual Financials
2020
2021
2022
2023
2024
2025
TTM
Revenue
11
17
27
25
30
33
19
Expenses
11
17
26
22
29
30
18
EBITDA
0
0
1
3
1
3
1
Operating Profit %
1 %
2 %
4 %
12 %
3 %
9 %
6 %
Depreciation
0
0
0
0
0
0
0
Interest
0
0
0
0
0
0
0
Profit Before Tax
0
0
1
3
1
3
1
Tax
0
0
0
1
0
1
-0
Net Profit
0
0
1
2
0
2
2
EPS in ₹
0.37
1.66
2.59
6.81
0.68
4.66
6.60

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
6
10
13
17
25
35
Fixed Assets
0
0
1
0
0
1
Current Assets
6
9
13
16
25
28
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
0
0
0
0
Other Assets
6
9
13
16
25
34
Total Equity & Liabilities
6
10
13
17
25
35
Current Liabilities
4
7
9
12
8
15
Non Current Liabilities
2
2
3
2
4
4
Total Equity
0
0
1
3
14
16
Reserve & Surplus
0
0
1
0
10
12
Share Capital
0
0
0
3
4
4

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
0
0
-0
0
Investing Activities
0
-0
-0
0
0
-1
Operating Activities
-1
0
-0
1
-15
1
Financing Activities
1
0
1
-1
15
-0

Share Holding

% Holding
Nov 2023
Mar 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
69.91 %
53.50 %
53.50 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
25.24 %
24.46 %
24.87 %
24.83 %
24.94 %
24.27 %
36.02 %
34.90 %
Others
4.85 %
5.63 %
5.22 %
5.26 %
5.15 %
5.82 %
10.48 %
11.60 %
No of Share Holders
742
580
505
487
459
455
498
491

Technical Indicators

RSI(14)
Neutral
52.95
ATR(14)
Less Volatile
2.69
STOCH(9,6)
Neutral
47.63
STOCH RSI(14)
Neutral
32.14
MACD(12,26)
Bullish
0.13
ADX(14)
Strong Trend
27.33
UO(9)
Bearish
44.01
ROC(12)
Downtrend And Accelerating
-2.05
WillR(14)
Neutral
-54.62